These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 15107064

  • 1. Treponema denticola immunoinhibitory protein induces irreversible G1 arrest in activated human lymphocytes.
    Lee W, Pankoski L, Zekavat A, Shenker BJ.
    Oral Microbiol Immunol; 2004 Jun; 19(3):144-9. PubMed ID: 15107064
    [Abstract] [Full Text] [Related]

  • 2. Sonicated extract of Enterococcus faecalis induces irreversible cell cycle arrest in phytohemagglutinin-activated human lymphocytes.
    Lee W, Lim S, Son HH, Bae KS.
    J Endod; 2004 Apr; 30(4):209-12. PubMed ID: 15085047
    [Abstract] [Full Text] [Related]

  • 3. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F, Moretti E, Sztein MB.
    Biol Res; 1993 Apr; 26(1-2):197-207. PubMed ID: 7670532
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG, Shi Y, Mills GB, Miller RG.
    Cell Immunol; 1996 Jun 15; 170(2):260-73. PubMed ID: 8660826
    [Abstract] [Full Text] [Related]

  • 5. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF, Mayor J, Ball C, Chitko-McKown CG, Sakata N, Domenico-Hahn J, Lucas JJ, Gelfand EW.
    Cell Immunol; 1999 Oct 10; 197(1):19-29. PubMed ID: 10555992
    [Abstract] [Full Text] [Related]

  • 6. Suppression of human lymphocyte responses by oral spirochetes: a monocyte-dependent phenomenon.
    Shenker BJ, Listgarten MA, Taichman NS.
    J Immunol; 1984 Apr 10; 132(4):2039-45. PubMed ID: 6699406
    [Abstract] [Full Text] [Related]

  • 7. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP, Saavedra R.
    Int Immunopharmacol; 2005 Dec 10; 5(13-14):1853-69. PubMed ID: 16275621
    [Abstract] [Full Text] [Related]

  • 8. Dual-parameter flow cytometric analysis of an early lymphocyte activation antigen (CK226) and DNA content.
    Zocchi MR, Heltai S, Poggi A.
    Cytometry; 1989 Nov 10; 10(6):762-71. PubMed ID: 2582967
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW.
    J Cell Physiol; 1993 Jan 10; 154(1):7-15. PubMed ID: 8419408
    [Abstract] [Full Text] [Related]

  • 10. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals.
    Mardiney M, Brown MR, Fleisher TA.
    Cytometry; 1996 Dec 15; 26(4):305-10. PubMed ID: 8979031
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes.
    Xu L, Liu Y, He X.
    Cell Mol Immunol; 2005 Aug 15; 2(4):295-300. PubMed ID: 16274628
    [Abstract] [Full Text] [Related]

  • 12. Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro.
    Masuyama J, Berman JS, Cruikshank WW, Morimoto C, Center DM.
    J Immunol; 1992 Mar 01; 148(5):1367-74. PubMed ID: 1371526
    [Abstract] [Full Text] [Related]

  • 13. [Effects of Forskolin on proliferation cell-cycle distribution and activation of the murine T lymphocytes in vitro].
    Song B, Zeng YY, Huang XY, Li L, Teng F, Yang Z, Yao ML.
    Zhong Yao Cai; 2008 Jul 01; 31(7):1008-12. PubMed ID: 18973017
    [Abstract] [Full Text] [Related]

  • 14. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro.
    Kaestel CG, Lovato P, Ødum N, Nissen MH, Röpke C.
    Curr Eye Res; 2005 May 01; 30(5):375-83. PubMed ID: 16020268
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
    Sztein MB, Kierszenbaum F.
    Immunology; 1991 Jun 01; 73(2):180-5. PubMed ID: 2071163
    [Abstract] [Full Text] [Related]

  • 17. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S, Schittenhelm M, Honecker F, Malenke E, Lauber K, Wesselborg S, Hartmann JT, Bokemeyer C, Mayer F.
    Int J Oncol; 2006 Aug 01; 29(2):471-9. PubMed ID: 16820891
    [Abstract] [Full Text] [Related]

  • 18. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression.
    Iwao Y, Hibi T, Watanabe M, Takaishi H, Hosoda Y, Hayashi A, Ohara M, Ogata H, Aiso S, Toda K.
    J Clin Lab Immunol; 1992 Aug 01; 38(1):15-27. PubMed ID: 1343345
    [Abstract] [Full Text] [Related]

  • 19. Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction.
    Williams JM, Loertscher R, Cotner T, Reddish M, Shapiro HM, Carpenter CB, Strominger JL, Strom TB.
    J Immunol; 1984 May 01; 132(5):2330-7. PubMed ID: 6325537
    [Abstract] [Full Text] [Related]

  • 20. Membrane IgM-stimulated human B lymphocytes succumb to activation-related apoptosis at a G1-->S transition: influence of ligand affinity and valency.
    Mongini PK, Vilensky MA, Highet PF, Inman JK.
    Cell Immunol; 1998 Sep 15; 188(2):137-50. PubMed ID: 9756644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.